Glatopa and Insomnia - a phase IV clinical study of FDA data

Summary:

Insomnia is reported as a side effect among people who take Glatopa (glatiramer acetate), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Vitamin D, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Insomnia when taking Glatopa. It is created by eHealthMe based on reports of 6,512 people who have side effects when taking Glatopa from the FDA, and is updated regularly.

What is Glatopa?

Glatopa has active ingredients of glatiramer acetate. eHealthMe is studying from 6,518 Glatopa users. Check the latest studies of Glatopa.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,118 drugs and 5,169 conditions by eHealthMe. Check the latest studies of Insomnia.

On Jul, 14, 2026

6,512 people reported to have side effects when taking Glatopa.
Among them, 45 people (0.69%) have Insomnia.

Among these 45 people:

How long have people been on Glatopa when they have Insomnia? *

What is the gender of people who have Insomnia when taking Glatopa? *

female: 68.18 %
male: 31.82 %

What is the age of people who have Insomnia when taking Glatopa? *

What are other drugs people take besides Glatopa? *

What are other side effects people have besides Insomnia? *

Injection Site Pain: 18 people, 40.00%
Injection Site Mass: 15 people, 33.33%
Headache (pain in head): 10 people, 22.22%
Pain: 9 people, 20.00%
Injection Site Bruising: 9 people, 20.00%
Injection Site Erythema (redness at injection site): 9 people, 20.00%
Weakness: 9 people, 20.00%
Fatigue (feeling of tiredness): 8 people, 17.78%
Injection Site Swelling: 8 people, 17.78%
Nausea (feeling of having an urge to vomit): 7 people, 15.56%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 37 people, 82.22%
Depression: 5 people, 11.11%
High Blood Cholesterol: 4 people, 8.89%
Pain In Extremity: 3 people, 6.67%
Neuralgia (pain in one or more nerves): 3 people, 6.67%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 6.67%
High Blood Pressure: 3 people, 6.67%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 2.22%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 1 person, 2.22%
Diabetes: 1 person, 2.22%

* Approximation only. Some reports may have incomplete information.

Do you take Glatopa and have Insomnia?

- Check whether Insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glatopa:

Glatopa (6,518 reports)

Insomnia treatments and more:

Insomnia (438,078 reports)

Browse all side effects of Glatopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Insomnia:

Insomnia (3,118 drugs)

Browse all the conditions that are associated with Insomnia:

Insomnia (5,169 conditions)

Related publications that referenced our studies

Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on glatiramer acetate (the active ingredients of Glatopa) and Glatopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.